Pages that link to "Q26783606"

The following pages link to Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis (Q26783606):

Displaying 25 items.

• Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression (Q26773413) (← links)
• Renin-angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review (Q35931751) (← links)
• Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol (Q36052362) (← links)
• Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis (Q36273664) (← links)
• Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis (Q36298209) (← links)
• Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α (PGC-1α) Regulates the Expression of B-Cell Lymphoma/Leukemia-2 (Bcl-2) and Promotes the Survival of Mesenchymal Stem Cells (MSCs) via PGC-1α/ERRα Interaction in the Absence of Serum, Hypox (Q38677244) (← links)
• Translation, but not transfection limits clinically relevant, exogenous mRNA based induction of alpha-4 integrin expression on human mesenchymal stem cells. (Q38691354) (← links)
• Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study (Q38708565) (← links)
• Cell therapy in chronic liver disease (Q38763661) (← links)
• Molecular Imaging of Stem Cell Transplantation for Liver Diseases: Monitoring, Clinical Translation, and Theranostics. (Q38772557) (← links)
• Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis (Q38931032) (← links)
• Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon (Q39429850) (← links)
• Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis (Q40629414) (← links)
• Transplantation of umbilical cord mesenchymal stem cells via different routes in rats with acute liver failure (Q42257806) (← links)
• Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis (Q47104014) (← links)
• Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study (Q47296990) (← links)
• Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial (Q50236829) (← links)
• A pooled analysis of mesenchymal stem cell-based therapy for liver disease. (Q52644305) (← links)
• Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension. (Q55363090) (← links)
• Zebularine Promotes Hepatic Differentiation of Rabbit Bone Marrow Mesenchymal Stem Cells by Interfering with p38 MAPK Signaling (Q58577511) (← links)
• Expansion and Characterization of Mesenchymal Stromal Cells from Peritoneal Dialysis Effluent in a Human Protein Medium (Q58585642) (← links)
• Stem cell transplantation for the treatment of patients with type 1 diabetes mellitus: A meta-analysis. (Q64964165) (← links)
• Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives (Q90459409) (← links)
• AT-MSCs Antifibrotic Activity is Improved by Eugenol through Modulation of TGF-β/Smad Signaling Pathway in Rats (Q92732900) (← links)
• Wikidata:Database reports/Constraint violations/P275 (← links | edit)